BioCentury
ARTICLE | Clinical News

All-In-One: Clinical trial started

February 18, 2013 8:00 AM UTC

Svelte began the international DIRECT II trial to compare its IDS vs. the Resolute Integrity drug-eluting stent in 159 patients. Medtronic Inc. (NYSE:MDT, Minneapolis, Minn.) markets Resolute Integr...